Position in SEER
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$22,092
-$66,192 QoQ
Shares Held
13,150
-67.7% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SEER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026XTX Topco Ltd holds $285,597,237 across 374 Biotechnology names. SEER ranks #332 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
255,431 | $7,075,438 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,632 | $6,980,313 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
80,519 | $6,046,171 | |
| 4 | EXEL |
Exelixis, Inc.
|
134,413 | $5,764,973 | |
| 5 | NUVL |
Nuvalent, Inc.
|
53,354 | $5,466,117 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
160,880 | $5,442,570 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
93,609 | $5,287,972 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
59,502 | $5,174,888 |
All Filings in SEER
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,092 | 13,150 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $88,284 | 40,684 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $171,831 | 80,295 | Shares | Defined | 2025-08-12 | |
| 2024-09-30 | $122,514 | 62,190 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $105,375 | 47,681 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $100,532 | 23,544 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $300,350 | 77,811 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $115,530 | 19,919 | Shares | Defined | 2023-02-14 | |
| 2021-09-30 | $234,424 | 6,789 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||